5-Sulfosalicylic Acid Dihydrate [For Biochemical Research] 98.0%(HPLC)

Glycopyrrolate(Glycopyrronium Br) is a muscarinic competitive antagonist used as an antispasmodic.IC50 ValueTarget mAChR (Muscarinic acetylcholine receptor M1)in vitro Glycopyrrolate showed no selectivity in its binding to the M1-M3 receptors.

For R&D use onlynot for drug household or other uses.

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the bloodbrain barrier and consequently has no to few central effects. A synthetic quaternary amine it is available in oral and intravenous (i.v.) forms. It was developed by Sosei and licensed to Novartis in 2005. The cation which is the active moiety is also known as Glycopyrronium.